Navigation Links
New Study Links Weed-Killer Glyphosate to Autism
Date:3/9/2017

LENEXA, Kan., March 8, 2017 /PRNewswire/ -- The peer-reviewed journal IMCJ (Integrative Medicine: A Clinician's Journal) just published a study by The Great Plains Laboratory, Inc. in the February/March 2017 issue indicating a connection between the herbicide glyphosate found in products such as Roundup™ and many other commercial herbicides (weed killers) and the presence of autism.  The World Health Organization International Agency for Research on Cancer published a summary in March 2015 that classified glyphosate as a probable carcinogen in humans.  The new study article is also available at www.PubMed.com.  

The complete title of the article is "Elevated Urinary Glyphosate and Clostridia Metabolites with Altered Dopamine Metabolism in Triplets with Autistic Spectrum Disorder or Suspected Seizure Disorder: A Case Study"and here is a link to that article:

The Great Plains Laboratory, Inc.
The Great Plains Laboratory, Inc.

https://www.greatplainslaboratory.com/articles-1/2017/2/13/elevated-urinary-glyphosate-and-clostridia-metabolites-with-altered-dopamine-metabolism-in-triplets-with-autistic-spectrum-disorder-or-suspected-seizure-disorder-a-case-study

William Shaw, Ph.D. of The Great Plains Laboratory, Inc in Lenexa, KS found very high amounts of glyphosate in urine samples of each of the triplets. The amount of glyphosate in the urine dropped dramatically after implementing a diet of only organic foods, with improvements noted in the functioning of the children. The two boys of the triplet set have autism while the girl of the triplet set had some other medical problems but does not have autism. The study's finding is significant because previous studies have shown that the rate of autism in the United States is highly correlated with the increased usage of glyphosate.

The study is also significant because it demonstrates a potential mechanism by which glyphosate could cause brain damage. People are exposed to high amounts of glyphosate when they consume genetically modified foods that are engineered to survive the toxicity of glyphosate. Weeds that are not genetically modified die when exposed to glyphosate.

It was previously thought that mammals, including humans that lack the enzymes that weeds possess would not be subject to glyphosate toxicity. However, recent research has found that glyphosate also kills beneficial bacteria in the environment and in the intestinal tracts of farm animals and humans. Glyphosate kills these beneficial bacteria by the same mechanism that it kills weeds. Pathogenic bacteria such as Clostridia and Salmonella lack the genes that kill the beneficial bacteria and proliferate in the soil and in the intestinal tract when glyphosate is present. This factor was of importance in the two boys of the triplets since both of them had elevated values of markers in the urine that indicated Clostridia overgrowth.  These markers may alter brain metabolism and brain development by the inhibition of the key brain enzyme dopamine-beta-hydroxylase, which is responsible for the conversion of dopamine to norepinephrine, important neurotransmitters in the brain (neurotransmitters are molecules that transmit signals or messages in the brain). This inhibition of dopamine-beta-hydroxylase leads to the overproduction of dopamine which may be toxic and cause brain damage at high concentrations. Some drugs used to treat autism like Risperdal™ block the effects of excessive dopamine.

If you have any questions, please don't hesitate to contact me or Dr. Shaw directly at wshaw@gpl4u.com

Heather Getz
Senior Marketing Representative
The Great Plains Laboratory, Inc.
11813 W. 77th St., Lenexa, KS 66214
Phone: 913-341-8949 x.159
Fax: 913-341-6207
www.GreatPlainsLaboratory.com

Related Files

Elevated Urinary Glyphosate.pdf

Related Links

Company Website

Link to Study Article

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-study-links-weed-killer-glyphosate-to-autism-300420821.html


'/>"/>
SOURCE The Great Plains Laboratory, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Advocacy Study Highlights Top Locations for High-Growth Companies
2. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
3. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
4. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
7. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
8. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
11. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology:
(Date:7/21/2017)... CA (PRWEB) , ... July 21, 2017 , ... West ... “Tu” Tuantu Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West ... 27 years of experience in dermatology, skin cancer , and more. She graduated ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set of transitions ... timeline. This effect isolates horizontal and vertical lines of pixels and sorts their pixels ... or flipping animation and can be changed using a drop-down menu. Create amazing and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of medical ... , directed by Dr. Russell Horine, DC to their exclusive list of medical professionals. ... Russell Horine serving as the clinic director and his son Dr. Lee Horine and ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced ... Dunbar received his BS in Biology from LSU, graduating summa cum laude. He attended ... President. After his residency in St. Louis, Dr. Dunbar moved to New York to ...
Breaking Medicine News(10 mins):